BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 35812429)

  • 1. Identification of a Disease-Associated Network of Intestinal Immune Cells in Treatment-Naive Inflammatory Bowel Disease.
    van Unen V; Ouboter LF; Li N; Schreurs M; Abdelaal T; Kooy-Winkelaar Y; Beyrend G; Höllt T; Maljaars PWJ; Mearin ML; Mahfouz A; Witte AMC; Clemens CHM; Abraham S; Escher JC; Lelieveldt BPF; Pascutti MF; van der Meulen-de Jong AE; Koning F
    Front Immunol; 2022; 13():893803. PubMed ID: 35812429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal CD103+CD4+ and CD103+CD8+ T-Cell Subsets in the Gut of Inflammatory Bowel Disease Patients at Diagnosis and During Follow-up.
    Roosenboom B; Wahab PJ; Smids C; Groenen MJM; van Koolwijk E; van Lochem EG; Horjus Talabur Horje CS
    Inflamm Bowel Dis; 2019 Aug; 25(9):1497-1509. PubMed ID: 30918941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-Cell Analyses of Colon and Blood Reveal Distinct Immune Cell Signatures of Ulcerative Colitis and Crohn's Disease.
    Mitsialis V; Wall S; Liu P; Ordovas-Montanes J; Parmet T; Vukovic M; Spencer D; Field M; McCourt C; Toothaker J; Bousvaros A; ; ; Shalek AK; Kean L; Horwitz B; Goldsmith J; Tseng G; Snapper SB; Konnikova L
    Gastroenterology; 2020 Aug; 159(2):591-608.e10. PubMed ID: 32428507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct patterns of naive, activated and memory T and B cells in blood of patients with ulcerative colitis or Crohn's disease.
    Rabe H; Malmquist M; Barkman C; Östman S; Gjertsson I; Saalman R; Wold AE
    Clin Exp Immunol; 2019 Jul; 197(1):111-129. PubMed ID: 30883691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with inflammatory bowel disease (IBD) reveal increased induction capacity of intracellular interferon-gamma (IFN-gamma) in peripheral CD8+ lymphocytes co-cultured with intestinal epithelial cells.
    Bisping G; Lügering N; Lütke-Brintrup S; Pauels HG; Schürmann G; Domschke W; Kucharzik T
    Clin Exp Immunol; 2001 Jan; 123(1):15-22. PubMed ID: 11167992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating CD4(+) and CD8(+) T cells are activated in inflammatory bowel disease and are associated with plasma markers of inflammation.
    Funderburg NT; Stubblefield Park SR; Sung HC; Hardy G; Clagett B; Ignatz-Hoover J; Harding CV; Fu P; Katz JA; Lederman MM; Levine AD
    Immunology; 2013 Sep; 140(1):87-97. PubMed ID: 23600521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
    Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
    Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent clonal expansions of peripheral blood CD4+ lymphocytes in chronic inflammatory bowel disease.
    Probert CS; Chott A; Turner JR; Saubermann LJ; Stevens AC; Bodinaku K; Elson CO; Balk SP; Blumberg RS
    J Immunol; 1996 Oct; 157(7):3183-91. PubMed ID: 8816432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating and intestinal regulatory T cells in inflammatory bowel disease: A systemic review and meta-analysis.
    Duan S; Cao Y; Chen P; Yang Y; Zhang Y
    Int Rev Immunol; 2024; 43(2):83-94. PubMed ID: 37615427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal T Cell Profiling in Inflammatory Bowel Disease: Linking T Cell Subsets to Disease Activity and Disease Course.
    Smids C; Horjus Talabur Horje CS; Drylewicz J; Roosenboom B; Groenen MJM; van Koolwijk E; van Lochem EG; Wahab PJ
    J Crohns Colitis; 2018 Mar; 12(4):465-475. PubMed ID: 29211912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4 T-Cell Subsets and the Pathophysiology of Inflammatory Bowel Disease.
    Gomez-Bris R; Saez A; Herrero-Fernandez B; Rius C; Sanchez-Martinez H; Gonzalez-Granado JM
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36769019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chromatin and single-cell transcriptional landscapes of CD4 T cells in inflammatory bowel disease link risk loci with a proinflammatory Th17 cell population.
    Medina TS; Murison A; Smith M; Kinker GS; Chakravarthy A; Vitiello GAF; Turpin W; Shen SY; Yau HL; Sarmento OF; Faubion W; Lupien M; Silverberg MS; Arrowsmith CH; De Carvalho DD
    Front Immunol; 2023; 14():1161901. PubMed ID: 37600767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subsets of mononuclear phagocytes are enriched in the inflamed colons of patients with IBD.
    Liu H; Dasgupta S; Fu Y; Bailey B; Roy C; Lightcap E; Faustin B
    BMC Immunol; 2019 Nov; 20(1):42. PubMed ID: 31718550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate Lymphoid Cells in Intestinal Homeostasis and Inflammatory Bowel Disease.
    Saez A; Gomez-Bris R; Herrero-Fernandez B; Mingorance C; Rius C; Gonzalez-Granado JM
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel CD8+ T-Cell Subsets Demonstrating Plasticity in Patients with Inflammatory Bowel Disease.
    Tom MR; Li J; Ueno A; Fort Gasia M; Chan R; Hung DY; Chenoo S; Iacucci M; Jijon HB; Kaplan GG; Beck PL; Panaccione R; Barkema HW; Buret AG; Yajnik V; Ghosh S
    Inflamm Bowel Dis; 2016 Jul; 22(7):1596-608. PubMed ID: 27306067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced CD27
    Pararasa C; Zhang N; Tull TJ; Chong MHA; Siu JHY; Guesdon W; Chavele KM; Sanderson JD; Langmead L; Kok K; Spencer J; Vossenkamper A
    Front Immunol; 2019; 10():361. PubMed ID: 30891036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic analysis of the inflamed intestinal mucosa reveals distinctive immune response profiles in Crohn's disease and ulcerative colitis.
    Berndt U; Bartsch S; Philipsen L; Danese S; Wiedenmann B; Dignass AU; Hämmerle M; Sturm A
    J Immunol; 2007 Jul; 179(1):295-304. PubMed ID: 17579049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A galectin-specific signature in the gut delineates Crohn's disease and ulcerative colitis from other human inflammatory intestinal disorders.
    Papa Gobbi R; De Francesco N; Bondar C; Muglia C; Chirdo F; Rumbo M; Rocca A; Toscano MA; Sambuelli A; Rabinovich GA; Docena GH
    Biofactors; 2016; 42(1):93-105. PubMed ID: 26891020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass cytometry and single-cell RNA sequencing reveal immune cell characteristics of active and inactive phases of Crohn's disease.
    Lin W; Liu S; Huang Z; Li H; Lu T; Luo Y; Zhong J; Xu Z; Liu Y; Li Y; Li P; Xu Q; Cai J; Li H; Chen XL
    Front Med (Lausanne); 2022; 9():1064106. PubMed ID: 36714133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.